2 active not recruiting, 1 completed. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Active not recruiting 2, Completed 1 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow Lymphoid Interstitial Pneumonia: new trials by email Literature Review of Lymphoid Interstitial Pneumonia trials Research Report on Lymphoid Interstitial Pneumonia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers Atezolizumab, Bevacizumab, Biospecimen Collection - Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma | Phase 2 / Phase 3 | Active not recruiting | National Cancer Institute (NCI) | 430 | 2023-03-13 | 2026-11-12 |
| Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Bevacizumab, Carboplatin, Cisplatin - Neck Squamous Cell Carcinoma of Unknown Primary, Recurrent Hypopharyngeal Squamous Cell Carcinoma | Phase 3 | Active not recruiting | National Cancer Institute (NCI) | 403 | 2008-08-08 | 2026-11-13 |
| Pilocarpine in Preventing Mucositis and Dry Mouth in Patients Receiving Radiation Therapy for Head and Neck Cancer pilocarpine hydrochloride, Placebo - Head and Neck Cancer, Oral Complications | Phase 3 | Completed | Radiation Therapy Oncology Group | 249 | 1998-03-01 | 2015-11-17 |
Squamous Cell Carcinoma of Head and Neck (3) · Carcinoma (1) · Head and Neck Neoplasms (1) · Hypopharyngeal Neoplasms (1) · Laryngeal Neoplasms (1) · Mouth Neoplasms (1) · Nasopharyngeal Carcinoma (1) · Oropharyngeal Neoplasms (1) · Salivary Gland Neoplasms (1) · Tongue Neoplasms (1)
Carcinoma, Squamous Cell (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · Neoplasms by Site (3) · Neoplasms, Glandular and Epithelial (3) · Carcinoma (2) · Head and Neck Neoplasms (2) · Mouth Diseases (2) · Stomatognathic Diseases (2) · Laryngeal Diseases (1) · Mouth Neoplasms (1) · Nasopharyngeal Diseases (1) · Nasopharyngeal Neoplasms (1) · Otorhinolaryngologic Diseases (1) · Otorhinolaryngologic Neoplasms (1)
1,2-diaminocyclohexaneplatinum II citrate (2) · Bevacizumab (2) · Carboplatin (2) · Cisplatin (2) · Disulfides (2) · Docetaxel (2) · Immunoglobulin G (2) · Platinum (2) · (225)Ac-DOTA-c(RGDyK) (1) · Cetuximab (1) · Fluorouracil (1) · Magnetic Resonance Spectroscopy (1) · Pilocarpine (1) · Specimen Handling (1) · atezolizumab (1)
National Cancer Institute (NCI) (2) · Radiation Therapy Oncology Group (1)
United States (3) · Canada (1) · Puerto Rico (1) · South Africa (1)
Aarti Bhatia (1) · Francis G. LeVeque, DDS (1)
PMID 12788192, PMID 16724649, PMID 31618129
U10CA180820 (2), U10CA021115 (1)